[Parkinsonism and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (review of the literature)]

[Article in Russian]

Review

[Article in Russian]

M A Atadzhanov. Zh Nevropatol Psikhiatr Im S S Korsakova. 1991.

. 1991;91(4):117-21.

No abstract available

Similar articles

[An experimental model of Parkinson disease caused by a neurotoxin: implications in the clinical aspects and the etiology of Parkinson disease].
Jiménez Jiménez FJ, Ladero Quesada JM. Jiménez Jiménez FJ, et al. Med Clin (Barc). 1990 Apr 21;94(15):585-95. Med Clin (Barc). 1990. PMID: 2192210 Review. Spanish. No abstract available.
[MPTP parkinsonism].
Kondo T. Kondo T. Ryoikibetsu Shokogun Shirizu. 1999;(27 Pt 2):37-40. Ryoikibetsu Shokogun Shirizu. 1999. PMID: 10434585 Review. Japanese. No abstract available.
[Clinical and biochemical parameters of parkinsonism induced by 1-methyl-4-phenyl-1,2,2,6-tetrahydropyridine and its methyl-phenyl and methoxy-phenyl derivatives in C57Bl/6 mice].
Lermontova NN, Soliakov LS, Bachurin SO, Serkova TP, Petrova LN, Dranyĭ OA, Tkachenko SE, Kalashnikov VV. Lermontova NN, et al. Biull Eksp Biol Med. 1990 Oct;110(10):397-9. Biull Eksp Biol Med. 1990. PMID: 2279092 Russian.
[MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and parkinsonism].
Gao XM, Ku BS. Gao XM, et al. Sheng Li Ke Xue Jin Zhan. 1989 Apr;20(2):161-3. Sheng Li Ke Xue Jin Zhan. 1989. PMID: 2686017 Review. Chinese. No abstract available.
Secondary (toxic) parkinsonism as model of Parkinson's disease.
Riederer P, Sofic E, Heuschneider G, Benedetti MS, Dostert P. Riederer P, et al. Funct Neurol. 1988 Oct-Dec;3(4):449-57. Funct Neurol. 1988. PMID: 3072280 Review. No abstract available.